The field component of the study took place at four transboundary sampling sites spanning the borders of Laos, Cambodia and Thailand, a region where human movement, trade and seasonal labor constantly shuffle malaria parasites across national boundaries. Between 2017 and 2019, the researchers deployed battery-operated CDC light traps for overnight collections, a method that captures host-seeking mosquitoes without requiring human landing catches and that can be standardized across sites with different ecologies and levels of health infrastructure. In total, 650 Anopheles specimens were gathered. Rather than relying on the wing markings and leg patterns that have traditionally guided morphological identification in Southeast Asia, a region notorious for cryptic species complexes, the team sequenced two molecular markers for each mosquito: the cytochrome c oxidase subunit 2 gene, carried in the mitochondria, and the internal transcribed spacer 2 region, found in the nuclear genome. Using both markers in combination allowed the researchers to resolve species boundaries with far greater confidence than either marker alone, a critical step because misidentified vectors can lead elimination programs to target the wrong insects with the wrong tools.

The molecular inventory revealed fifteen Anopheles species across the four sites, and the composition of these assemblages shifted markedly from location to location. Two species dominated the overall catch: Anopheles kochi, which accounted for 38.46 percent of identified specimens, and Anopheles sinensis, which made up 21.69 percent. This spatial heterogeneity matters operationally. A national malaria control program that assumes a single dominant vector across its territory may find that bed net distribution, indoor residual spraying or larval source management calibrated for one species misses the breeding habits and biting behaviors of another. In the Greater Mekong Subregion, where residual malaria transmission increasingly happens outdoors, among forest goers, and in cattle sheds rather than inside sprayed houses, knowing exactly which anophelines are present at which border crossing is a prerequisite for designing interventions that actually reach them.

Among the collected mosquitoes were eighteen individuals of Anopheles peditaeniatus, a member of the Anopheles hyrcanus group, and it was this species that became the focus of the study’s resistance analysis. The researchers targeted two of the most important known mutations in mosquito insecticide genetics. The first is the knockdown resistance mutation, or kdr, at position L1014F in the voltage-gated sodium channel gene, the classic mechanism by which mosquitoes survive pyrethroid exposure, the chemical class that coats the vast majority of long-lasting insecticide-treated nets distributed worldwide. The second is the G119S substitution in the acetylcholinesterase-1 gene, abbreviated ace-1, which confers resistance to organophosphates and carbamates by altering the very enzyme those insecticides are designed to inhibit. Using targeted sequencing of these two loci, the team genotyped their An. peditaeniatus specimens with single-nucleotide precision.

The results were striking. Not a single kdr L1014F mutation was detected in any of the tested species, a reassuring signal that pyrethroid resistance via this particular mechanism has not yet taken hold in these populations. The ace-1 locus told a very different story. Of the eighteen An. peditaeniatus individuals genotyped, only five, or 27.8 percent, were homozygous for the wild-type susceptible allele, designated GG. Twelve individuals, a full 66.7 percent, were heterozygous carriers of the resistance allele, designated GS, and one individual, 5.6 percent, was homozygous resistant, designated SS. In population genetics terms, this means the resistance allele is already circulating at an allele frequency of roughly 39 percent in this small sample, and the presence of a homozygous resistant individual demonstrates that the allele is viable in the field, not merely an occasional immigrant or laboratory artifact. Because the G119S mutation is known to impose fitness costs on mosquitoes in the absence of insecticide pressure, its high frequency suggests that organophosphate or carbamate exposure, whether from agricultural spraying, public health campaigns or both, has been selecting for it in these border populations.

The authors draw a direct operational conclusion from this finding: insecticide rotation strategies in the region need to be tailored, not generic. If a control program rotates from pyrethroids to organophosphates assuming a clean resistance slate, it may walk directly into a population already carrying ace-1 resistance at meaningful frequency. Conversely, the absence of kdr mutations suggests pyrethroid-based tools such as long-lasting insecticide-treated nets, abbreviated LLINs and central to malaria control across the Greater Mekong Subregion, may retain their efficacy for now, provided resistance is monitored continuously rather than assumed. The study’s genotyping framework, built on targeted sequencing of just two loci, is cheap enough to be folded into routine surveillance, turning each mosquito collection into an early warning system for resistance emergence.

The third pillar of the study looked forward rather than backward, asking where An. peditaeniatus will be able to live as the climate warms. The researchers employed maximum entropy modeling, known as MaxEnt, a widely used ecological niche modeling technique that estimates a species’ potential geographic distribution by relating known occurrence records to environmental variables. The model was trained on 108 occurrence points for the species and 19 bioclimatic variables drawn from the WorldClim version 2.1 database at a spatial resolution of 2.5 arc minutes, roughly 4.6 kilometers at the equator. The baseline climate layer represented the period from 1970 to 2000, while future projections covered 2021 to 2040 under multiple Shared Socioeconomic Pathway scenarios, abbreviated SSPs, which describe different combinations of greenhouse gas trajectories and socioeconomic development. The climate model used to generate these future layers was the Beijing Climate Center Climate System Model version 2-Medium Resolution, or BCC-CSM2-MR, one of the models contributing to the most recent international climate assessments.

The MaxEnt models performed well by the standard area-under-the-curve metric, and they identified three climatic variables as the principal drivers of habitat suitability for An. peditaeniatus. The first is BIO6, the minimum temperature of the coldest month, which essentially defines the thermal floor below which the species cannot survive the winter. The second is BIO18, the precipitation of the warmest quarter, a proxy for the availability of the standing water habitats in which anopheline larvae develop during the hottest part of the year. The third is BIO4, temperature seasonality, which captures the annual amplitude of thermal variation and shapes the timing and duration of breeding seasons. Together, these variables describe a species whose fortunes hinge on the intersection of warmth and wetness, precisely the combination that climate change is reshaping most dramatically across monsoon Asia.

The projected maps diverged sharply depending on the emissions pathway. Under the intermediate SSP245, the pessimistic SSP370 and the high-emission SSP585 scenarios, highly suitable habitat for An. peditaeniatus expanded markedly in the tri-border region where Laos, Cambodia and Thailand meet, suggesting that under most plausible futures, this vector’s operational range will grow rather than shrink in the coming two decades. Under the most ambitious mitigation scenario, SSP126, the pattern reversed: suitable habitat fragmented, with core suitable areas contracting to major wetlands. The contrast is a vivid illustration of how climate policy and malaria policy are entangled. Every fraction of a degree of avoided warming, in this model, translates directly into less contiguous territory for a proven malaria vector, while unmitigated warming hands the mosquito new ground precisely where three national control programs must coordinate their efforts.

The study’s authors argue that these three lines of evidence, species inventories, resistance genotyping and habitat projections, should be integrated into cross-border surveillance systems rather than treated as separate academic exercises. Laos has made remarkable progress against malaria over the past two decades, aided by artemisinin-based combination therapies, insecticide-treated nets and community-level village health workers, yet transmission persists in a heterogeneous pattern fueled by mobile and migrant populations, forest exposure and imported infections from neighboring countries. In that context, a map of where An. peditaeniatus habitat is expanding, overlaid with data on which mosquitoes carry which resistance alleles, becomes a targeting tool: it tells programs where to intensify monitoring, which insecticide classes to deploy or avoid, and where cross-border coordination with Cambodian and Thai counterparts will matter most. As climate change redraws the boundaries of vector habitat across the Greater Mekong Subregion, the study suggests that the countries that treat mosquito genetics and ecological forecasting as routine surveillance infrastructure, rather than occasional research projects, will be the ones that reach elimination first.

Subject of Research: Anopheline species diversity, ace-1 insecticide resistance, and climate-driven habitat suitability modeling of Anopheles peditaeniatus in Lao PDR border regions

Article Title: Anopheline diversity, ace-1 resistance and climate-driven habitat projections for Anopheles peditaeniatus in Lao PDR border regions

Article References: Zhang, J., Zhao, X., Yan, Z., Yang, R., Wu, L., Luo, C., Zhang, C., & Zhang, Y. (2026). Anopheline diversity, ace-1 resistance and climate-driven habitat projections for Anopheles peditaeniatus in Lao PDR border regions. Parasites & Vectors. https://doi.org/10.1186/s13071-026-07592-x

Image Credits: AI Generated

DOI: 10.1186/s13071-026-07592-x

Keywords: Anopheles peditaeniatus, malaria, insecticide resistance, ace-1 G119S, kdr mutation, MaxEnt modeling, climate change, Lao PDR, Greater Mekong Subregion, Anopheles hyrcanus group, habitat suitability, vector surveillance

The work was led by Ellen A. Kearney of the University of Melbourne and the Burnet Institute, together with colleagues in Australia and Myanmar, including senior author Freya J. I. Fowkes. Their target was gSG6-P1, a peptide derived from the Anopheles gambiae Salivary Gland 6 protein. Antibodies against gSG6-P1 have been widely proposed as biomarkers of Anopheles biting exposure, but the authors note that most studies to date have been descriptive. What has been missing is a direct quantification of how an intervention changes antibody levels — both immediately and cumulatively over time — in a controlled trial setting.

The setting was the Greater Mekong Subregion, a hotspot of malaria transmission where elimination efforts face a stubborn problem: many infections occur among mobile and hard-to-reach populations, such as migrants and forest workers, who sleep outdoors or far from formal health services. In this context, personal protection tools like topical repellents are attractive because they do not depend on people being inside a bed net or a sprayed house. But measuring whether such tools actually reduce biting exposure across whole communities has been difficult, since mosquito counts and human landing catches are labour-intensive and imprecise.

To answer the question, the team drew on a stepped-wedge cluster randomised controlled trial in which personal repellent was distributed to 114 villages in Southeast Myanmar. In a stepped-wedge design, all clusters eventually receive the intervention, but the timing of the rollout is randomised, with villages crossing over from control to intervention in monthly blocks. This structure allows researchers to compare periods before and after intervention delivery within the same communities, while controlling for secular trends in transmission. The trial is registered in the Australian New Zealand Clinical Trials Registry and was approved by ethics committees in Myanmar and Australia, with informed consent collected from all participants or their guardians.

The serological engine of the study was a high-throughput enzyme-linked immunosorbent assay, or ELISA, run on an extraordinary 14,128 samples. Many of these were dried blood spots, a sampling format well suited to remote field settings because it requires only a finger-prick of blood that can be stored and transported without a cold chain. The assay quantified IgG antibodies specific to the gSG6-P1 peptide, expressed as optical density values, and classified participants as seropositive or seronegative depending on whether their signal exceeded a defined threshold.

The baseline picture was striking. Across the study population, antibody levels were generally high, with a median optical density of 2.1, and 59.9 percent of participants were seropositive for anti-gSG6-P1 IgG. In other words, roughly six in ten people carried measurable evidence of recent Anopheles biting. That prevalence alone confirms that the biomarker registers meaningful exposure in this setting, but the crucial question was whether the numbers would move when the repellent arrived.

Using generalised linear mixed-effects modelling, the researchers estimated both the instantaneous effect of repellent distribution — the change in antibody levels at the moment villages transitioned to the intervention — and a series of lagged effects designed to capture cumulative impact. The logic behind the lagged models is important: antibodies do not vanish overnight. If a repellent reduces biting, existing antibodies should decay gradually as the immune response wanes, so the effect of sustained repellent use should only emerge over subsequent months. The modelling therefore tested whether antibody levels fell in the months following distribution, treating the antibody response as a slowly turning dial rather than a switch.

The headline result was nuanced. Overall, there was no instantaneous effect of repellent on anti-gSG6-P1 IgG levels, with a mean difference of just 0.01 optical density units and a confidence interval spanning zero (95 percent CI −0.02 to 0.04; p = 0.583). When the team modelled delayed effects, the estimates pointed in the expected direction but remained statistically inconclusive: repellent distribution six months prior was associated with a 0.02-unit decrease in antibody levels (95 percent CI −0.07 to 0.03; p = 0.381). The picture sharpened, however, when the analysis was stratified by risk group. Migrants showed a statistically significant reduction in antibody levels at the six-month lag, with a mean difference of −0.10 (95 percent CI −0.20 to −0.001; p = 0.048), while forest dwellers showed a borderline reduction of −0.05 (95 percent CI −0.10 to 0.005; p = 0.075). Village residents, by contrast, showed no reduction at all (mean difference 0.02; 95 percent CI −0.04 to 0.08; p = 0.489).

That pattern makes biological sense. Migrants and forest dwellers are precisely the groups whose exposure is hardest to control with bed nets and indoor residual spraying, and who spend the most time in transmission hotspots. If a topical repellent works anywhere, it should work for people who apply it while exposed to intense outdoor biting. Yet the authors are careful to temper the interpretation: the magnitudes of the observed effects were small, and the confidence intervals were often wide, meaning the data cannot rule out effects ranging from negligible to modest. The study also did not find convincing changes in the odds of seropositivity, suggesting that the continuous antibody level may be a more sensitive metric than a binary seropositive classification in trials of this kind.

Even so, the study delivers something the field has lacked: empirical parameters on antibody kinetics in a real intervention trial. Knowing how quickly anti-gSG6-P1 IgG responds — and how slowly it decays — tells future trial designers how long they must wait after an intervention begins before antibody outcomes can be expected to move, and how large a sample they need to detect the change. The authors conclude that antibodies to Anopheles salivary proteins could serve as an informative outcome measure in vector-control trials, particularly in settings where conventional entomological monitoring is impractical. As malaria elimination programs in the Greater Mekong Subregion push into their endgame, tools that can quietly read a community’s biting exposure from a drop of dried blood may prove indispensable for knowing whether the last miles of the campaign are actually being won.

Subject of Research: Using anti-gSG6-P1 salivary antibodies as biomarkers of Anopheles biting exposure in a topical repellent trial

Article Title: Anopheles salivary antibody biomarker outcomes to assess the effectiveness of topical repellent in Southeast Myanmar

Article References: Kearney, E. A., Agius, P. A., O’Flaherty, K., Oo, W. H., Cutts, J. C., Htike, W., Da Silva Gonçalves, D., Thi, A., Aung, K. Z., Thu, H. K., Thein, M. M., Zaw, N. N., Htay, W. Y. M., Soe, A. P., Simpson, J. A., & Fowkes, F. J. I. (2026). Anopheles salivary antibody biomarker outcomes to assess the effectiveness of topical repellent in Southeast Myanmar. Parasites & Vectors. https://doi.org/10.1186/s13071-026-07694-6

Image Credits: AI Generated

DOI: 10.1186/s13071-026-07694-6

Keywords: malaria, Anopheles, salivary biomarkers, gSG6-P1, vector control, topical repellent, serology, ELISA, Myanmar, Greater Mekong Subregion, stepped-wedge trial, IgG antibodies